Inovio Pharmaceuticals targets transformation of monoclonal antibody therapies

Inovio Pharmaceuticals, Inc. has announced the publication of a peer-reviewed paper demonstrating the success of its new DNA plasmid technology in generating therapeutic monoclonal antibodies.

http://www.medilexicon.com/medicalnews.php?newsid=266547